4.7 Article

DNA methylation-based signature of CD8+tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer

William M. Grady et al.

Summary: Colorectal cancer, liver cancer, stomach cancer, pancreatic cancer, and esophageal cancer are leading causes of cancer-related deaths worldwide. Gastrointestinal cancers are characterized by genomic and epigenomic DNA alterations. Epigenetic alterations have emerged as robust biomarkers for cancer screening and surveillance.

GASTROENTEROLOGY (2021)

Article Medicine, Research & Experimental

Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer

Zijian Chen et al.

Summary: This study found that the NTRK3 gene promoter was more frequently methylated in CRC, leading to suppressed gene expression. It was confirmed that NTRK3 promoter methylation was associated with survival outcome in CRC and a nomogram predicting survival outcome was developed. Moreover, NTRK3 promoter methylation also predicted survival outcomes in other tumors.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Review Oncology

The Immunoscore: Colon Cancer and Beyond

Helen K. Angell et al.

CLINICAL CANCER RESEARCH (2020)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Gastroenterology & Hepatology

Epigenetics of colorectal cancer: biomarker and therapeutic potential

Gerhard Jung et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Biotechnology & Applied Microbiology

Nomograms for Prediction of Molecular Phenotypes in Colorectal Cancer

Zhuojun Yu et al.

ONCOTARGETS AND THERAPY (2020)

Article Medical Laboratory Technology

Novel Assay for Quantitative Analysis of DNA Methylation at Single-Base Resolution

Huichuan Yu et al.

CLINICAL CHEMISTRY (2019)

Review Gastroenterology & Hepatology

Immunotherapy in colorectal cancer: rationale, challenges and potential

Karuna Ganesh et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Biotechnology & Applied Microbiology

Determining cell type abundance and expression from bulk tissues with digital cytometry

Aaron M. Newman et al.

NATURE BIOTECHNOLOGY (2019)

Review Medical Laboratory Technology

Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients

Michael J. Duffy et al.

CLINICAL CHEMISTRY (2019)

Review Oncology

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Jonathan J. Havel et al.

NATURE REVIEWS CANCER (2019)

Article Public, Environmental & Occupational Health

Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC)

Mark A. Jenkins et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)

Article Genetics & Heredity

DNA methylation loss in late-replicating domains is linked to mitotic cell division

Wanding Zhou et al.

NATURE GENETICS (2018)

Editorial Material Gastroenterology & Hepatology

Evading the immune response in metastasis

Katrina Ray

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Biochemistry & Molecular Biology

ZBTB24 is a transcriptional regulator that coordinates with DNMT3B to control DNA methylation

Joyce J. Thompson et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Multidisciplinary Sciences

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors

Thomas Duhen et al.

NATURE COMMUNICATIONS (2018)

Article Genetics & Heredity

Adjusting for Batch Effects in DNA Methylation Microarray Data, a Lesson Learned

E. M. Price et al.

FRONTIERS IN GENETICS (2018)

Article Biotechnology & Applied Microbiology

A comprehensive analysis of 195 DNA methylomes reveals shared and cell-specific features of partially methylated domains

Abdulrahman Salhab et al.

GENOME BIOLOGY (2018)

Article Medicine, Research & Experimental

DNA methylation-based immune response signature improves patient diagnosis in multiple cancers

Jana Jeschke et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Oncology

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

Sotirios P. Fortis et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)

Article Cell & Tissue Engineering

DNA Methylation Dynamics of Human Hematopoietic Stem Cell Differentiation

Matthias Farlik et al.

CELL STEM CELL (2016)

Review Oncology

Microsatellite Instability as a Biomarker for PD-1 Blockade

Jonathan C. Dudley et al.

CLINICAL CANCER RESEARCH (2016)

Review Genetics & Heredity

The importance of detailed epigenomic profiling of different cell types within organs

Theresa Ryan Stueve et al.

EPIGENOMICS (2016)

Article Oncology

Functional impairment of infiltrating T cells in human colorectal cancer

Edward S. Taylor et al.

ONCOIMMUNOLOGY (2016)

Article Oncology

Association of the Colorectal CpG Island Methylator Phenotype with Molecular Features, Risk Factors, and Family History

Daniel J. Weisenberger et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)

Article Gastroenterology & Hepatology

Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival

Amanda I. Phipps et al.

GASTROENTEROLOGY (2015)

Article Medicine, General & Internal

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

D. T. Le et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Oncology

Colon cancer family registry: An international resource for studies of the genetic epidemiology of colon cancer

Polly A. Newcomb et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)

Article Biochemistry & Molecular Biology

MethyLight: a high-throughput assay to measure DNA methylation

Cindy A. Eads et al.

NUCLEIC ACIDS RESEARCH (2000)